Diabetes Board decisions

The Board denied service connection for renal cell carcinoma, atrial fibrillation, diabetes mellitus, and benign prostatic hypertrophy as the evidence did not establish a link between these conditions and service.

The Veteran's service connection for peripheral vascular disease is granted as secondary to his service-connected diabetes mellitus. The TDIU claim remains denied.

The Veteran's service-connected diabetic nephropathy, arterial hypertension, and peripheral vascular disease have not been manifested by persistent edema or albuminuria with BUN of 40 to 80 mg% or creatinine of 4 to 8 mg%, which would warrant a higher rating. The claim for increased ratings is denied.

The Veteran's diabetes mellitus, type II is not service connected due to lack of evidence showing a link between his military service and the condition.

The Veteran's Type II diabetes mellitus with peripheral neuropathy and proteinuria is currently rated at 100 percent since September 4, 2007.,Diabetic nephropathy has been rated at 80 percent since May 12, 2009.

The Veteran's claims for service connection for diabetes mellitus and hypertension due to herbicide exposure are denied as there is no evidence of herbicide exposure in his military service. The claim for secondary service connection for hypertension due to diabetes mellitus also fails.

The Veteran's diabetes mellitus, type II, was not incurred or aggravated during his military service and is not presumed to be due to exposure to herbicides. The evidence does not show a current disability during service or immediately thereafter.

The Veteran's claim for service connection for Type II diabetes mellitus was received on March 30, 2004. The effective date of his award is set to the day following receipt of his original claim.

The Board has determined that the Veteran's claimed psychiatric, knee, and unspecified joint disabilities are not related to his active service. The claims for these conditions have been denied.

The Veteran's service connection for peripheral neuropathy of the upper extremities was restored, and his rating for DM, Type II with hypertension and erectile dysfunction was maintained at 20 percent.

The Veteran's appeal is remanded for further development, including consideration of service connection claims and TDIU eligibility. The case will be returned to the Board after these issues are adjudicated.

The Board has determined that additional development is needed to verify the Veteran's exposure to herbicides, which may affect his claims for service connection for diabetes mellitus type II and peripheral neuropathy. The case will be remanded for this purpose.

The Board found no evidence of exposure to Agent Orange or any other herbicide in the Veteran's service records. The claims for diabetes mellitus, type II; lung cancer; prostate cancer; and hypertension were all denied as there is insufficient evidence linking these conditions to his military service.

The Board has determined that the diagnosis of type II diabetes mellitus on which service connection was predicated was clearly and unmistakably erroneous, thus denying restoration of service connection for this condition.

The Board has determined that the Veteran did not have herbicide exposure during service, and therefore cannot establish presumptive service connection for diabetes mellitus. The claim is denied as there is no direct evidence linking the current condition to service.

The Veteran is granted SMC at the N rate due to having suffered loss of use of both legs and a separate service-connected disability (PTSD) rated as 100 percent disabling or more.

The Board denied service connection for diabetes mellitus, finding no competent and credible evidence of exposure to Agent Orange or any other herbicide during service. The Veteran's claim was based on his assertion that he cleaned dirty vehicles in Okinawa, Japan, which were covered in Agent Orange.

The Board denied service connection for chronic inflammation affecting the entire body, diabetes mellitus, left elbow injury residuals, and obesity. The claims were adjudicated based on direct service connection.

The Veteran's diabetes mellitus, type II, is currently evaluated at 60 percent and the Board finds that an increased rating beyond this level is not warranted. The Veteran does not have episodes of hypoglycemia requiring hospitalization or complications warranting a separate compensable evaluation.

The Board has determined that the Veteran's death was not caused by a service-connected condition, and therefore denied the claim for service connection for the cause of his death.